期刊文献+

血清超敏C反应蛋白在慢性乙型肝炎进展中的意义 被引量:8

Clinical significance of high-sensitivity C-reactive protein in development of chronic hepatitis
原文传递
导出
摘要 目的探讨血清超敏c反应蛋白(hs-CRP)在慢性乙型肝炎(CHB)进展中的意义。方法总共182例未经治疗的CHB患者和50名健康对照被纳入研究。对所有患者的血清hs-CRP水平与患者的年龄、性别、病史、血清HBVDNA水平、肝功能、肝脏硬度检测值(LsM)和肝组织纤维化分期进行了相关性分析。计量资料以均数±标准差G士s)表示,正态分布的均数比较用t检验,非正态分布的均数比较用秩和检验;相关性检验采用Pearson相关分析,等级相关性采用Spearman分析。结果CHB患者血清hs-CRP水平[(2.38±2.79)mg/L]显著高于健康对照[(0.78±1.07)mg/hl,t=2.495,P〈0.05。血清hs-CRP水平与患者年龄、性别和病程无明显相关眭泸〉0.05),与HBVDNA水平、总胆红素、ALT、AST和LSM呈正相关(r值分别为0.159,0.271,0.298,0.389,0.562,P值均〈0.05);血清CRP水平与肝功能损害程度、LSM和肝组织纤维化分期呈正相关(r值分别为0.340,0.292,0.434,P值均〈0.01)。结论血清hs-CRP与CHB病毒的复制、肝功能损害程度及肝纤维化进展密切相关,但受肝功能损害程度的影响较大,其能否作为肝纤维化分期的指标尚需深入研究。 Objective To explore the clinical significance of high-sensitivity C-reactive protein (hs- CRP) in the development of chronic hepatitis B (CI-IB). Methods A total of 182 patients with untreated CHB and 50 healthy individuals (controls) participated in the study. Correlation analysis was performed to determine the association of serum hs-CRP with the age, sex, medical history, serum hepatitis B virus (HBV) DNA, liver function parameters, liver stiffness measure (LSM) and hepatic fibrosis; in addition, correlation analysis was carried out for the associations of degree of liver damage with grade of hepatic fibrosis, LSM and the serum levels ofhs-CRP. Results CHB patients showed significantly higher serum hs-CRP levels than healthy controls (2.38±2.79 vs. 0.78±1.07; t = 2.495, P 〈 0.05). Serum hs-CRP levels were significantly correlated with HBV DNA (r = 0.159), liver function parameters (total bilirubin, r = 0.271; alanine aminotransferase, r = 0.298; aspartate aminotransferase, r = 0.389), and LSM, r = 0.562) (all P 〈 0.05). The correlations with liver function (r = 0.340), LSM (r = 0.292) and hepatic fibrosis grade were positive (r = 0.434) (allP 〈 0.01). Conclusion Serum hs-CRP levels in CHB patients can reflect degree of liver damage and of liver fibrosis.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2015年第7期498-501,共4页 Chinese Journal of Hepatology
基金 宁夏科技攻关项目,中国肝炎防治基金会王宝恩肝纤维化研究基金(xjs)
关键词 肝炎 乙型 慢性 肝硬化 C反应蛋白 FIBROSCAN Hepatitis B, chronic Liver cirrhosis C -reactive protein FibroScan
  • 相关文献

参考文献12

  • 1Maleki I, Rastgar A, Hosseini V, et al. High sensitive CRP and pentraxine 3 as noninvasive biomarkers of nonalcoholic fatty liver disease[Y], Eur Rev Med Phamaacol Sei, 2014, 18(11): 1583-1590.
  • 2Komoriya T, Inoue N, Yoshimune K, et al. Use of a highly sensitive latex reagent with amino acid spacer for determination of C-reactive protein concentration in a variety of liver diseases[J]. J Biosci Bioeng, 2012, 114(5): 560-563.
  • 3Atta M, Cabral M, Santos G, et al. Inflammation biomarkers in chronic hepatitis C: association with liver histopathology, HCV genotype and cryoglobulinemia[J]. Inflamm Res, 2012, 61(10): 1101- 1106.
  • 4Andreozzi P, Viscogliosi G, Colella F, et al. Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation[Y]. Recenti Prog Med, 2012, 103(12):570-574.
  • 5Sj6wall C, Cardell K, Bostr6m EA, et al. High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation[J]. Hum Immunol, 2012, 73(4): 382-388.
  • 6贾继东,李兰娟.慢性乙型肝炎防治指南(2010年版)[J].中华肝脏病杂志,2011,19(1):13-24. 被引量:3213
  • 7Shameem M, Bhargava R, Abroad Z, et al. Association betweenserum C- reactive protein levels and other important predictive markers of outcome in COPD[J]. Acta Med Iran, 2011, 49(1): 18-20.
  • 8瞬时弹性成像技术诊断肝纤维化专家意见[J].中华肝脏病杂志,2013,21(6):420-424. 被引量:177
  • 9Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastogTdphy[J]. J Hepatol, 2008, 48(5): 835- 847.
  • 10Corpechot C, Carrat F, Poujol-Robert A, et al. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis[J]. Hepatology, 2012, 56(1): 198-208.

二级参考文献19

共引文献3410

同被引文献94

  • 1陈建江,任玉华.乙型肝炎的流行病学特点及防治措施探讨[J].世界最新医学信息文摘,2019,0(90):387-387. 被引量:5
  • 2Shahnaz Sali,Mohammad Darvishi,Mojtaba GhasemiAdl,Meisam Akhlaghdoust,Azin Mirzazadeh,Somayeh Elikaei Behjati,Hossein Sheikh-Zeinolabedini,Shervin Shokouhi,Soheil Tavakolpour.Comparing the Efficacy and Safety of Treating Chronic Hepatitis B Infection during Pregnancy with Lamivudine,Telbivudine,and Tenofovir:A Meta-analysis[J].Journal of Clinical and Translational Hepatology,2019,7(3):197-212. 被引量:6
  • 3宋琳,谭德明,方志雄.淀粉样蛋白a在治疗慢性丙型肝炎患者中的临床意义[J].中华临床感染病杂志,2008,1(2). 被引量:3
  • 4赵景民,周光德,李文淑,王松山,孙艳玲,杨建法,潘登,张玲霞,郭顺根,牛建昭,陈菊梅.复方鳖甲软肝片抗肝纤维化机制的实验研究[J].解放军医学杂志,2004,29(7):560-562. 被引量:104
  • 5S hahidS M , Fatima SN , Mahboob T. Angiotensin convertingenzyme (ACE) gene expression in experimentally induced livercirrhosis in rats. Pak J Pharm Sci,2013,26: 853-857.
  • 6Lee JY , Lee JH , K m DK, et al. C-reactive protein as a prognosticfactor for mortality in pneumonia patients with liver cirrhosis.IIepatogastroenterol,2014,61: 1331-1338.
  • 7Kim SR , Kondo F , Otono Y , et a l Serum amyloid A and C -reactive protein positive nodule in alcoholic liver cirrhosis, hardto make definite diagnosis. Hepatol R es,2014,44: 584-590.
  • 8Lin K H , Wong F L , Wu M S, et al. Serum procalcitonin and Creactiveprotein levels as markers of bacterial infection inpatients with liver cirrhosis: a systematic review and metaanalysis.Diagn Microbll Infec Dis,2014,80:72-78.
  • 9Di Martino V, Coutris C, Cervoni JP, et al. Prognostic value ofC-reactive protein levels in patients with cirrhosis LiverTransplant,2015, 21: 753-760.
  • 10Alempijevit: T ,Sokic-Milutinovic A,ToncevL,etal. Primarybiliary cirrhosis and hepatic sarcoidosis: a case reportVoinosantt Pregl,2 0 1 4,7 1 :83-86.

引证文献8

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部